A Case Control Study of Vitamin D Levels in Chronic Obstructive Pulmonary Disease Patients and Healthy Volunteers in South Gujarat, India

Authors

  • Kunal A Patel Surat Municipal Institute of Medical Education and Research, Surat, India
  • Parth H Patel Surat Municipal Institute of Medical Education and Research, Surat, India
  • Manan P Vaid Surat Municipal Institute of Medical Education and Research, Surat, India
  • Vinod Dandge Surat Municipal Institute of Medical Education and Research, Surat, India

DOI:

https://doi.org/10.55489/njmr.12042022931

Keywords:

Vitamin D, COPD, PFT, BMI, Chemiluminescence Immunoassay (CLIA) technique

Abstract

Introduction: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) programme states that COPD is a common, treatable, and preventable disease that is characterized by a persistent airflow restriction that usually progresses and is connected to an exaggerated chronic inflammatory response in the airways and the lung to harmful particles or gases. The combined severity of a patient's co-morbid illnesses and exacerbations increases. The purpose of the study was to assess the vitamin D status of COPD patients and healthy participants.

Methodology: This case-control study was conducted among 75 cases and 75 control at the Surat Municipal Institute of Medical Education and Research General Medicine department.

Result: The mean vitamin D of subjects in cases was 32.21 ± 12.68 and it was 52.05 ± 1.99 in controls. The difference in vitamin D between the two groups was statistically significant (P Value<0.001).

Conclusion: COPD patients had lower amounts of vitamin D. As COPD severity increases, vitamin D levels decrease. Along with a rise in COPD exacerbations, vitamin D levels are also decreasing.

 

References

World Health Organization. Chronic obstructive pulmonary disease (COPD). [Online].; 2015 [cited 2015 12 1. Available from: www.who.int/respiratory/copd/en/.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. Doi: https://doi.org/10.1371/journal.pmed.0030442 PMid:17132052 PMCid:PMC1664601

Jindal SK (2006) Emergence of chronic obstructive pulmonary disease as an epidemic in India. Indian J Med Res 124: 619-630.

GOLD- the Global Initiative for Chronic Lung Disease. [Online].; 2015[cited 2015 Dec15. Available from: www.goldcopd.org/uploads/users/files/GOLD_ Pocket_ 2015_ Feb18.pdf

Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591. Doi: https://doi.org/10.1093/ajcn/85.6.1586 PMid:17556697

Garland CF, Gorham ED, Mohr SB, Garland FC (2009) Vita-min D for cancer prevention: global perspective. Ann Epidemiol 19: 468-483. Doi: https://doi.org/10.1016/j.annepidem.2009.03.021 PMid:19523595

Stechschulte SA, Kirsner RS, Federman DG (2009) Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 122:793-802. Doi: https://doi.org/10.1016/j.amjmed.2009.02.029 PMid:19699370

Pongron .G, Kennan A.L, DE LucA H F "Activation" of Vitamin D by the Liver. J Clin Invest. 1969; 48(11):2032-2037. Doi: https://doi.org/10.1172/JCI106168 PMid:4310770 PMCid:PMC297455

Zhang J, Lin XF, Bai CX. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2014; 9: p. 57-63. Doi: https://doi.org/10.2147/COPD.S52416 PMid:24426780 PMCid:PMC3890400

Dhadke VN, Dhadke SV, Raut N. Clinical profile in chronic obstructive pulmonary disease patients and their evaluation with spirometry and 2D ECHO. International Journal of Cur-rent Research. 2015 Feb; 7(2): p. 12480-12488.

Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene; Thorax. 2010 Mar;65(3):215-220. Doi: https://doi.org/10.1136/thx.2009.120659 PMid:19996341

Persson LJ, Aanerud M, Hiemstra PS, et al. Chronic obstructive pulmonary disease is associated with low levels of vitamin D; PLoS ONE. 2012;7(6):e38934. Doi: https://doi.org/10.1371/journal.pone.0038934 PMid:22737223 PMCid:PMC3380863

Thakuria R, Maitra T, Deka J. Vitamin D Deficiency: A Factor for Exacerbation of COPD: Myth or Fact.

Monadi M, Heidari B et al. Relationship between serum vita-min D and forced expiratory volume in patients with chronic obstructive pulmonary disease (COPD). Caspian J Intern Med 2012; 3(3): 451-455.

Downloads

Published

2022-12-31

How to Cite

Patel, K. A., Patel, P. H., Vaid, M. P., & Dandge, V. (2022). A Case Control Study of Vitamin D Levels in Chronic Obstructive Pulmonary Disease Patients and Healthy Volunteers in South Gujarat, India. National Journal of Medical Research, 12(04), 73–76. https://doi.org/10.55489/njmr.12042022931

Issue

Section

Original Research Articles